U.S. markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
78.70-0.65 (-0.82%)
At close: 04:00PM EST
77.11 -1.59 (-2.02%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close79.35
Bid77.35 x 1000
Ask82.18 x 900
Day's Range77.07 - 80.94
52 Week Range49.24 - 94.57
Avg. Volume139,604
Market Cap1.372B
Beta (5Y Monthly)0.92
PE Ratio (TTM)25.97
EPS (TTM)3.03
Earnings DateMay 02, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 02, 2010
1y Target Est116.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for LGND

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ligand Pharmaceuticals Incorpor
    LGND: Raising target price to $89.00LIGAND PHARMACEUTICALS has an Investment Rating of HOLD; a target price of $89.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more